AESTURA

AESTURA is a South Korean dermocosmetic brand with roots dating back to 1982, when it was launched by Pacific Pharmaceuticals; unlike typical cosmetic brands, it originated from a pharmaceutical company initially focused on treatments for skin disorders, and entered the cosmeceutical market under the AESTURA name in 2012. In 2021, Amorepacific Corporation absorbed AESTURA through a merger, integrating it as a business unit within the group. The brand is known as Korea's No. 1 dermatologist-recommended brand, with hero lines including ATOBARRIER365, THERACNE365, DERMAUV365, and REGEDERM365, supported by an in-house Derma Lab with over 470 papers on basic research and 240 patents. Its philosophy is rooted in the encounter between pharmaceutical heritage and Amorepacific's skin science, collaborating with dermatologists to address the problems of sensitive skin.